Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS-methylphenidate trial in young male prisoners with ADHD
2015-004271-78Phase 4Completed
- Sponsor
- King's College London
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in attention deficit hyperactivity disorder (ADHD) comparing Concerta XL with Placebo (2 arms). Primary endpoint: ADHD symptoms. Started Mar 2016; status: completed.
02
Drugs
methylphenidate hydrochloride OROS
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2015-004271-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004271-78.